Antidepresant effects of Cinnamon (Cinnamomum burmannii) extract in depressed induced rats using 3-minutes Tail Suspension method by Parisa, Nita et al.
                                                                                                             ISSN 2598 0580 
 
 
 Bioscientia Medicina Page 1 
 
 
Bioscientia Medicina Volume 3, Issue 3 , Page No: 1-8 
Available online : www.bioscmed.com     
Bio Sc Med 3(3) :1-8  
 
Antidepresant effects of Cinnamon (Cinnamomum burmannii) extract in depressed induced 
rats using 3-minutes Tail Suspension method 
 
Nita Parisa1, Mayasari2#, Nia Savitri Tamzil1, Bintang Arroyantri3, Ziske Maritska4 
1Department  of Pharmacology, Faculty of Medicine, Universitas Sriwijaya 
2Undergraduate, Faculty of Medicine, Universitas Sriwijaya 
3Department of Psychiary, Faculty of Medicine, Universitas Sriwijaya 
4Department of Biology Medicine, Faculty of Medicine, Universitas Sriwijaya 
 
# Corresponding Author: Mayasari.may4sari@gmail.com  
Received   : June 19th 2019 




The increasing prevalence of depression gives rise to challenges in not only elucidating its diverse causes, but also 
in finding an effective treatment. One of the factors linked to depression is the imbalance of serotonin, norepinephrine, and 
dopamine neurotransmitters.  Cinnamon (Cinnamomum burmannii) as one of the world’s wellknown cooking ingredients 
is believed to be able to regulate the neurotransmitters imbalance with the help of terpenoids and flavonoid polyphenols as 
one of its content. 
Objective 
This study aims to determine the effectiveness of cinnamon extract as an antidepressant in depressed induced 
animal model. 
Methods 
An experimental in vivo with pre-post control group design was conducted in twenty five Wistar strain white rats 
that were divided into 5 treatment groups that received fluoxetine as positive control, aquades, and different dose of 
cinnamon extracts (50 mg/kgBW, 100 mg/kgBW, and 200 mg/kgBW).  Depression induction method used was 3-minute 
Tail Suspension Test, done for 14 days. The antidepressant effectiveness test was carried out by calculating the immobility 
time duration with Forced Swimming Test method and was further analyzed using one-way ANOVA test. 
Results 
One-way ANOVA test results showed that there were differences in the mean duration of immobility time between 
treatment groups after being given cinnamon extract (p value = 0,000). Groups that were given 100 mg/kgBW cinnamon 
extract and 200 mg /kgBW showed a p value>0.05 when compared with positive control group receiving Fluoxetine 
although displayed a similar reduced immobility time. 
Conclusion 
Cinnamon (Cinnamomum burmannii) extract showed a promising potential as an effective antidepressant tested 
in animal model. 
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Depression is a condition that contributes greatly to the occurrence of suicides every year1. The 
prevalence of depression continues to increase with a risk of two to three times more frequent in 
women than men. Depression itself is characterized by emotional disorders in the form of depressive 
affect, anxiety, decreased concentration, loss of interest, and loss of energy in doing daily activities. It 
is known to be influenced by several factors including genetics, environmental, one’s personality, as 
well as abnormalities in the number and function of neurotransmitters in body.  
Depression is often not only a one-time episode but it can occur repeatedly, leading to 
impairment in one’s activities.  A person who experienced depression should be treated with proper 
management, one of them is pharmacological treatment.  Current drug of choice for depression is the 
Selective Serotonin-Reuptake Inhibitor (SSRI) group which has lower side effects compared to 
previous drug of choice which was MAOI antidepressants and tricyclics2.  Yet the use of SSRI shows 
various side effects such as sexual dysfunction in women in the form of decreased libido, and 
anorgasmia arousal and erectile dysfunction in men 21.  
Cinnamon (Cinnamomum burmannii) as one of the commonly found cooking ingredients 
worldwide including in Indonesia is believed to provide health benefits. Cinnamon (Cinnamomum 
burmannii) contains various chemical compounds like flavonoid and terpenoid polyphenols that work 
as an antidepressant through a mechanism that is in line with the theory of BDNF's influence on 
depression, neuroinflammation, and the presence of free radicals in the pathogenesis of depression 
hypothesis 3,4,5  As a traditional herb with long history of usage in cooking, it is also believed that 
cinnamon posseses a very small risk of toxicity. Thus it is believed to be an alternative treatment for 
depression with a minimum side effects.  
 
Methods  
This was an experimental in vivo study with pre-post control group design. As many as twenty 
five white male wistar rats were divided into 5 groups. The first group was administered with 
fluoxetine as a positive control, the second group was administered with aquadest as a negative control, 
third, fourth, and fifth group were administered with various dose of Cinnamon extracts, namely 50 
mg/KgBW, 100 mg/KgBW and 200mg/KgBW. 
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Phytochemical Test  
 In this study, a phytochemical test was conducted to identify active compounds in the cinnamon 
extract. The examinations carried out were tests of flavonoids, phenols, alkaloids, quinones, steroids, 
saponins, and tannins.   
Cinnamon Extract  
Two hundred and fifty grams of powder Simplicia cinnamon was macerated with 96% ethanol. 
Extracts was then obtained through evaporation using vacuum rotary evaporator, before it then dried 
and crushed to homogeneous.  
Administration of antidepressant drugs  
The antidepressant drug as positive control being used in this study was a 20 mg fluoxetine 
capsules. Since the usual dosage in adult humans is around 20mg, then the dose of Fluoxetine for mice 
is being converted with following equation: 70/50 x 20mg x 0.018 = 0.504 mg / 200gBW = 2.52 mg / 
KgBW (0.018 is the dose conversion factor from human to rat). 
Antidepressant Test for Cinnamon Extracts 
Twenty five rats were divided into 5 groups where it underwent the depression induction for 
two weeks. All the animals were hanging in a pole as high as ± 50 cm for 3 minutes before they were 
being weighted and observed for depression behavior.  After being treated with cinnamon extracts for 
two weeks, the test animals then underwent a post-test which is Forced Swimming Test (FST) to assess 
the effectiveness of each cinnamon extracts6.7. The FST was carried out in an open tube (± 50 height 
cm, 20 cm in diameter) containing water with a height of 30 cm. The last 8 minutes, 2 minutes of the 
first as acclimatization and 6 minutes as the calculation of immobility time of test animals.   
 
Results 
Results manufacture simple worth as much as 250 grams of the extract obtained as much as 26 
grams with results Rdt 10%.  The phytochemical test was carried out to cinnamon extract with the 
following results:  
 Table 1. Phytochemical Test  
Examination  Results  Identification  
Phenol  colour black strong   +  
Flavonoids  colour orange   +  
Alkaloids  formed colour red   +  
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Steroids  Blue    +  
Saponin  
1.5 cm foam not lost given HCL 
2N    +  
Quinon  Red    +  
Tanin  Black      +   
 
There were behavioural changes observed after the induction.  Majority of the rats showed a decreased 
appetite hence the decreasing body weight as it can be seen on table 1.  The rats also showed passive 
behaviour compared to before induction. 
 
Table 1. Body Weight Before and After Induction  
Group  N  
Before Weight Loss Induction  
Average ± SD  
Body Weight After Induction  
Average ± SD  
Fluoxetine 5  218.6 ± 7.7  212.8 ± 12.3  
Aquades  5  215.6 ± 8.1  211.6 ± 11.1  
Cinnamon Extract 50  5  203.8 ± 4.7  181 ± 17.8  
Cinnamon Extract 100  5  197.4 ± 3.5  198.8 ± 8.4  
Cinnamon Extract 200  5  210.2 ± 13.6  197.4 ± 12.2  
 
Soon after each group was being given cinnamon extract for two weeks, a post-test was carried out. 
Immobility time data is presented in the following table 2.  
 
Table 2. Differences between immobility time pre-test and post-test  
Treatment Group  
Immobility Time Pre  
± SD  
Immobility Time Post  
± SD  
p-value  
  
Fluoxetine  142.8 ± 8.07  62.8 ± 8.4  0,000  
Aquades  133.4 ± 10.9  145.2 ± 9.7  0.226  
Cinnamon Extract 50  140.4 ± 6.02  134.8 ± 7.79  0.181  
Cinnamon Extract 100  135.4 ± 6, 2  74.8 ± 7.75  0,000  
Cinnamon Extract 200  142.4 ± 14.7  61.2 ± 13.1  0,000  
Paired Sample T Test , p <0.05  
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Differences in immobility time pre-test and post-test in each treatment group was analyzed using the 
Paired Sample T Test.  As it can  be seen in table 2, there were differences in the mean Immobility time 
pre-test and post test in three groups: fluoxetine group ( p value = 0,000), cinnamon extract 100 
mg/kgBW ( p value = 0,000), cinnamon extract 200 mg/kgBW ( p value = 0,000).  The other two 
groups which are aquades ( p value = 0.226), and cinnamon extract 50mg/kgBW ( p value = 0.181), 
showed no differences in mean immobility time pre-test and post-test.  
  
Table 3. Differences in Average Immobility Time Post-Test  
Treatment Group  N  Average ± SD  P value  
Fluoxetine 5  63.8 ± 8.4  
0,000  
Aquades  5  147.2 ± 9.7  
Cinnamon Extract 50  5  137.8 ± 7.7  
Cinnamon Extract 100  5  78.8 ± 7.7  
Cinnamon Extract 200  5  66.2 ± 13.1  
one way anova , p <0.05  
  
Based on the one-way ANOVA test, difference meaningful immobility time deliver group treatment, 
then post hoc tests were compared to each treatment group. fluoxetine group compared with the 
Aquades group and the group of cinnamon extract dose 50 mg / kgBW obtained p-value 0,000 ( p 
<0.05) the meaning different significant whereas the fluoxetine group is compared with cinnamon 
extract dose of 100mg / kgBW ( p-value = 0.225 ) and 200 mg / kgBW ( p-value = 1,000) which 
means there is no significant difference on group, so be concluded that the dose of cinnamon extract 
having an effective similar to those observed with fluoxetine in reducing immobility time on rat there 
is on cinnamon extract of 100mg / kgBW and 200mg / kgBW.  
 
Discussions 
Before the test animals were given an induction of depression, all test animals were weighted.  
After the two weeks induction, the test animals were weighted again.  It can be inferred from table 1 
that there were changes in weight before and after the induction.  These changes might be due to 
changes in appetite becaused of the occurence of depression in animal test.  Dietary symptoms 
including changes in appetite are one of the most commonly identified symptoms in depression.  Some 
experience decrease of appetite (35%), while some experience increase of appetite (48%).  These two 
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conditions are caused by different mechanism in quite a same pathway.  Major depression with an 
increased appetite is caused by increased activity of blood-oxygen-level-dependent (BOLD) in the 
brain involving the reward system (anterior insula, orbitofrontal cortex, ventral striatum, the ventral 
pallidum, and putamen), while major depression with decreased appetite decreases blood-oxygen-
level-dependent (BOLD) activity in the mid-insula part8. 
The cinnamon extracts contain various substances with cinnamaldehyde as the major 
component.  Cinnamaldehyde metabolism in the body produces sodium benzoate (NaB) metabollite 
where NaB is thought to be able to increase BDNF neurotrophin expression in vivo in rat3. In addition 
to cinnamaldehyde, cinnamon extracts also contain other active substances namely proanthocyanidin 
which includes condensed tannin compounds10.  Proanthocyanidin is proved to be protective against 
depression and anxiety, where it has antidepressant activity by increasing BDNF expression in the 
hippocampus and frontal cortex of chronically stressed mice11. The application of chronic stress can 
provide a variety of effects on the neuron system, one of which is a decrease in the synthesis of BDNF 
mRNA in the hippocampus which causes a decrease in serotonin as one of the most important factors 
in depression. In another study, it was found that administration of antidepressants can increase BDNF 
and the administration of BDNF infusion has an antidepressant effect12.  
In previous study it was stated that Cinnamon extracts increase dopamine at doses of 50 mg / 
kgBW, 100 mg / kgBW and 200 mg / kgBW13. In depression, dopamine dysfunction can cause 
dysregulation in the reward, arousal or spirit system, making depressed people became hedonic 
deficits14. Aqueous extract of cinnamon for 6 days can reduce lipopolysaccharide which induces tumour 
necrosis factor-α ( TNF-α) in serum. TNF-α is stated to be able to induce depressive behaviour, which 
in line with the discovery of elevated serum levels of IL-1β, IL-6, IL-8, IL-12 and TNF-α together with 
a decrease in anti-inflammatory IL-10 in depressed people15.  A meta-analysis study proves that there 
is a decrease in IL-1 β for administration antidepressant SSRI19. The presence of inflammation is 
thought to cause microglia activation which is associated with hippocampal connectivity disorders that 
affects on depression. Other hypothesis mechanism in depression like cytokine hypothesis, is the 
activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis.  Its activation leads to the increment of 
cortisol, responding to inflammation by inhibiting Nuclear Factor Kappa B (NF-kB). However, 
excessive cytokines due to persistent inflammation can activate P38 Mitogen-Activated Protein Kinase 
(MAPK).  This will further cause disruption of glucocorticoid receptor function which has an impact 
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on failure of inhibition in NF-kB, leading to failure in inhibiting of the production of excessive 
cytokines16. The next hypothesis is that cytokines will activate serotonin transporters, which is an 
extracellular transporters that work to bring back serotonin (5-HT) to pre synapse due to activation of 
P38 MAPK17. The final hypothesis of depression is indoleamine-stimulating 2,3- dioxygenase (IDO) 
cytokines. It is an enzyme that convert the amino acid tryptophan as a 5-HT precursor to a kynurenine 
metabolite so there will be an imbalance in serotonin availability.  This supports the results of research 
that proves the difference in 5-HT ratio to Kynurenine metabolites are found to be higher in depressed 
people18 .  
As previously stated, other than containing cinnamaldehyde, cinnamon is also known to 
contain others substances, like linalool and eugenol for intstance.  These two substances are known to 
reduce lipid oxidation 19. This function matters because lipid peroxidase will increase in conditions of 
psychological stress such as depression. The presence of lipid peroxidase activity causes free radical 
formation in major depressed patients and Generalized Anxiety Disorder (GAD) with the discovery of 
malondialdehyde (MDA). Another pathogenesis of depression is the presence of an oxidant and 
antioxidant imbalances due to an increase in glucocorticoid secretion which causes an increase in 
reactive oxygen production (ROS). The presence of MDA as an indicator of oxidative stress can cause 
a decrease in serotonin and inhibit serotonin from binding to the receptor17,18.  
 
Conclusion  
Certain dose of cinnamon extracts work effectively as an antidepressant in Wistar strain white 
rats that were induced with depression through two weeks of 3-minutes Tail Suspension method.  
Further investigation on its antidepressant potential in humans is needed. 
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